SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hye Won Lee, Jun Yong Park, Sang Hoon Ahn, An evaluation of entecavir for the treatment of chronic hepatitis B infection in adults, Expert Review of Gastroenterology & Hepatology, 2016, 10, 2, 177

    CrossRef

  2. 2
    Lang Bai, Yunhong Nong, Ying Shi, Miao Liu, Libo Yan, Jin Shang, Feijun Huang, Yong Lin, Hong Tang, Luteolin Inhibits Hepatitis B Virus Replication through Extracellular Signal-Regulated Kinase-Mediated Down-Regulation of Hepatocyte Nuclear Factor 4α Expression, Molecular Pharmaceutics, 2016, 13, 2, 568

    CrossRef

  3. 3
    Yan Geng, Xiangling Wang, Xiaolan Lu, Xiaokang Wu, Nan Xu, Lei Han, Jiru Xu, Mutation Changes in the preC/Core Promoter in HBeAg-Positive Patients With Chronic Hepatitis B During Interferon Therapy, Medicine, 2016, 95, 5, e2657

    CrossRef

  4. 4
    Wan-Hsin Wen, Ming-Wei Lai, Mei-Hwei Chang, A review of strategies to prevent mother-to-infant transmission of hepatitis B virus infection, Expert Review of Gastroenterology & Hepatology, 2015, 1

    CrossRef

  5. 5
    Paul Martin, Daryl T.-Y. Lau, Mindie H. Nguyen, Harry L.A. Janssen, Douglas T. Dieterich, Marion G. Peters, Ira M. Jacobson, A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update, Clinical Gastroenterology and Hepatology, 2015, 13, 12, 2071

    CrossRef

  6. 6
    Ye Tao, Assaf Rotem, Huidan Zhang, Shelley K. Cockrell, Stephan A. Koehler, Connie B. Chang, Lloyd W. Ung, Paul G. Cantalupo, Yukun Ren, Jeffrey S. Lin, Andrew B. Feldman, Christiane E. Wobus, James M. Pipas, David A. Weitz, Artifact-Free Quantification and Sequencing of Rare Recombinant Viruses by Using Drop-Based Microfluidics, ChemBioChem, 2015, 16, 15
  7. 7
    Timothy M. Block, Siddhartha Rawat, Carol L. Brosgart, Chronic hepatitis B: A wave of new therapies on the horizon, Antiviral Research, 2015, 121, 69

    CrossRef

  8. 8
    Sangheun Lee, Jun Yong Park, Kijun Song, Do Young Kim, Beom Kyung Kim, Seung Up Kim, Hye Jin Ku, Kwang-Hyub Han, Sang Hoon Ahn, Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B, Gut and Liver, 2015, 9, 6, 776

    CrossRef

  9. 9
    Erik De Clercq, Current treatment of hepatitis B virus infections, Reviews in Medical Virology, 2015, 25, 6
  10. 10
    Xun Qi, Jinyu Wang, Liang Chen, Yuxian Huang, Yanli Qin, Richeng Mao, Jiming Zhang, Impact of Nucleos(t)ide Analogue Combination Therapy on the Estimated Glomerular Filtration Rate in Patients With Chronic Hepatitis B, Medicine, 2015, 94, 15, e646

    CrossRef

  11. 11
    L. Chen, Q.R. Gan, D.Q. Zhang, L.F. Yao, R.S. Lin, Q. Li, M.H. Lin, D.M. Yu, X.X. Zhang, C. Pan, Increased intrahepatic quasispecies heterogeneity correlates with off-treatment sustained response to nucleos(t)ide analogues in e antigen-positive chronic hepatitis B patients, Clinical Microbiology and Infection, 2015,

    CrossRef

  12. 12
    U. Hakan Yildiz, Fatih Inci, ShuQi Wang, Mehlika Toy, H. Cumhur Tekin, Asad Javaid, Daryl T.-Y. Lau, Utkan Demirci, Recent advances in micro/nanotechnologies for global control of hepatitis B infection, Biotechnology Advances, 2015, 33, 1, 178

    CrossRef

  13. 13
    M.-C. Tsai, C.-H. Chen, C.-H. Hung, C.-M. Lee, K.-W. Chiu, J.-H. Wang, S.-N. Lu, P.-L. Tseng, K.-C. Chang, Y.-H. Yen, T.-H. Hu, A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match–control study, Clinical Microbiology and Infection, 2014, 20, 2
  14. 14
    Li-Peng Qiu, Liang Chen, Ke-Ping Chen, Antihepatitis B therapy: a review of current medications and novel small molecule inhibitors, Fundamental & Clinical Pharmacology, 2014, 28, 4
  15. 15
    Chun-Ying Wu, Jaw-Town Lin, Hsiu J. Ho, Chien-Wei Su, Teng-Yu Lee, Shen-Yung Wang, Chuhui Wu, Jaw-Ching Wu, Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B—A Nationwide Cohort Study, Gastroenterology, 2014, 147, 1, 143

    CrossRef

  16. 16
    Sheng Liu, Wanxing Wei, Kaichuang Shi, Xun Cao, Min Zhou, Zhiping Liu, In vitro and in vivo anti-hepatitis B virus activities of the lignan niranthin isolated from Phyllanthus niruri L., Journal of Ethnopharmacology, 2014, 155, 2, 1061

    CrossRef

  17. 17
    Sheng Liu, Wanxing Wei, Yubin Li, Xing Lin, Kaichuang Shi, Xun Cao, Min Zhou, In vitro and in vivo anti-hepatitis B virus activities of the lignan nirtetralin B isolated from Phyllanthus niruri L., Journal of Ethnopharmacology, 2014, 157, 62

    CrossRef

  18. 18
    Amoreena C. Corsa, Yang Liu, John F. Flaherty, Ben Mitchell, Scott K. Fung, Edward Gane, Michael D. Miller, Kathryn M. Kitrinos, No Resistance to Tenofovir Disoproxil Fumarate Through 96 Weeks of Treatment in Patients With Lamivudine-Resistant Chronic Hepatitis B, Clinical Gastroenterology and Hepatology, 2014, 12, 12, 2106

    CrossRef

  19. 19
    Ender G Yegin, Osman Cavit Ozdogan, Partial virological response to three different nucleotide analogues in naive patients with chronic hepatitis B, Hepatobiliary & Pancreatic Diseases International, 2014, 13, 6, 602

    CrossRef

  20. 20
    Li-Peng Qiu, Ke-Ping Chen, Anti-HBV agents derived from botanical origin, Fitoterapia, 2013, 84, 140

    CrossRef

  21. 21
    Li-Yun Zheng, Li-Min Zang, Qing-Hua Yang, Wen-Quan Yu, Xian-Zhen Fang, Yu-Hai Zhang, Xue-Jie Zhao, Na Wan, Yue-Teng Zhang, Qing-Duan Wang, Jun-Biao Chang, Anti-hepatitis B virus activity of α-DDB–DU, a novel nucleoside analogue, in vitro and in vivo, European Journal of Pharmacology, 2013, 702, 1-3, 258

    CrossRef

  22. 22
    Sarah P. Katen, Zhenning Tan, Srinivas Reddy Chirapu, M.G. Finn, Adam Zlotnick, Assembly-Directed Antivirals Differentially Bind Quasiequivalent Pockets to Modify Hepatitis B Virus Capsid Tertiary and Quaternary Structure, Structure, 2013, 21, 8, 1406

    CrossRef

  23. 23
    Timothy M. Block, Robert Gish, Haitao Guo, Anand Mehta, Andrea Cuconati, W. Thomas London, Ju-Tao Guo, Chronic hepatitis B: What should be the goal for new therapies?, Antiviral Research, 2013, 98, 1, 27

    CrossRef

  24. 24
    Mehlika Toy, Cost-effectiveness of viral hepatitis B & C treatment, Best Practice & Research Clinical Gastroenterology, 2013, 27, 6, 973

    CrossRef

  25. 25
    Young Jip Kim, Kichan Kim, Sun Hyuk Hwang, Soon Sun Kim, Dami Lee, Jae Youn Cheong, Sung Won Cho, Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients, Clinical and Molecular Hepatology, 2013, 19, 3, 300

    CrossRef

  26. 26
    Stuart C. Gordon, Zahary Krastev, Andrzej Horban, Jörg Petersen, Jan Sperl, Phillip Dinh, Eduardo B. Martins, Leland J. Yee, John F. Flaherty, Kathryn M. Kitrinos, Vinod K. Rustgi, Patrick Marcellin, Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load, Hepatology, 2013, 58, 2
  27. 27
    Jun-Dong He, Jian-Mei Gao, Tao Shen, Robert W. Murphy, Xin-Min Yan, Evolutionary perspective on hepatitis B virus with an expanded sampling strategy, Virus Research, 2013, 178, 2, 525

    CrossRef

  28. 28
    Christine I Wooddell, David B Rozema, Markus Hossbach, Matthias John, Holly L Hamilton, Qili Chu, Julia O Hegge, Jason J Klein, Darren H Wakefield, Claudia E Oropeza, Jochen Deckert, Ingo Roehl, Kerstin Jahn-Hofmann, Philipp Hadwiger, Hans-Peter Vornlocher, Alan McLachlan, David L Lewis, Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection, Molecular Therapy, 2013, 21, 5, 973

    CrossRef

  29. 29
    Jason Lamontagne, Courtney Mills, Richeng Mao, Cally Goddard, Dawei Cai, Haitao Guo, Andy Cuconati, Timothy Block, Xuanyong Lu, Screening and identification of compounds with antiviral activity against hepatitis B virus using a safe compound library and novel real-time immune-absorbance PCR-based high throughput system, Antiviral Research, 2013, 98, 1, 19

    CrossRef

  30. 30
    Wai-Kay Seto, Man-Fung Yuen, James Fung, Ching-Lung Lai, Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection, Hepatology International, 2013, 7, 2, 327

    CrossRef

  31. 31
    Tomasz Pniewski, The Twenty-Year Story of a Plant-Based Vaccine Against Hepatitis B: Stagnation or Promising Prospects?, International Journal of Molecular Sciences, 2013, 14, 1, 1978

    CrossRef

  32. 32
    Stephanos J. Hadziyannis, Dimitrios Vassilopoulos, Emilia Hadziyannis, Antiviral Agents, 2013,

    CrossRef

  33. 33
    Wai-Kay Seto, Ching-Lung Lai, Man-Fung Yuen, Acute-on-chronic liver failure in chronic hepatitis B, Journal of Gastroenterology and Hepatology, 2012, 27, 4
  34. 34
    Qinghua Yang, Xuejie Zhao, Limin Zang, Xianzhen Fang, Jing Zhao, Xiaorui Yang, Qingduan Wang, Liyun Zheng, Junbiao Chang, Anti-hepatitis B virus activities of α-DDB–FNC, a novel nucleoside–biphenyldicarboxylate compound in cells and ducks, and its anti-immunological liver injury effect in mice, Antiviral Research, 2012, 96, 3, 333

    CrossRef

  35. 35
    Hye Sun Shin, Seung Up Kim, Jun Yong Park, Do Young Kim, Kwang-Hyub Han, Chae Yoon Chon, Oidov Baatarkhuu, Sang Hoon Ahn, Antiviral efficacy of lamivudine versus entecavir in patients with hepatitis B virus-related advanced hepatocellular carcinoma, Journal of Gastroenterology and Hepatology, 2012, 27, 9
  36. 36
    S. J. Hadziyannis, Commentary: combination therapy with two nucleos(t)ide analogues in chronic hepatitis B, Alimentary Pharmacology & Therapeutics, 2012, 35, 12
  37. 37
    Peter LM Jansen, Joep De Bruijne, Controlled-release interferon alpha 2b , a new member of the interferon family for the treatment of chronic hepatitis C, Expert Opinion on Investigational Drugs, 2012, 21, 1, 111

    CrossRef

  38. 38
    In O Sun, Yu Ah Hong, Hoon Suk Park, Sun Ryoung Choi, Byung Ha Chung, Cheol Whee Park, Chul Woo Yang, Yong Soo Kim, Bum Soon Choi, Experience of Anti-Viral Therapy in Hepatitis B-Associated Membranous Nephropathy, Including Lamivudine-Resistant Strains, The Korean Journal of Internal Medicine, 2012, 27, 4, 411

    CrossRef

  39. 39
    Yu-Bing Zhou, Ya-Feng Wang, Yan Zhang, Li-Yun Zheng, Xiao-Ang Yang, Ning Wang, Jin-Hua Jiang, Fang Ma, De-Tao Yin, Chang-Yu Sun, Qing-Duan Wang, In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates, European Journal of Pharmacology, 2012, 683, 1-3, 10

    CrossRef

  40. 40
    Tram T. Tran, Luis H. Ocampo, The patient, the doctor, and the system: Underdiagnosis and undertreatment of hepatitis B, Hepatology, 2012, 56, 2
  41. 41
    Yu Jin Kim, Seung Woon Paik, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Byung Chul Yoo, Viral response at 6 months is associated with treatment outcome of adefovir add-on therapy for lamivudine-resistance, Journal of Gastroenterology and Hepatology, 2012, 27, 9
  42. 42
    James M. Crawford, Alastair D. Burt, MacSween's Pathology of the Liver, 2012,

    CrossRef

  43. 43
    Hidehiro Kamezaki, Tatsuo Kanda, Shuang Wu, Shingo Nakamoto, Makoto Arai, Hitoshi Maruyama, Keiichi Fujiwara, Fumio Imazeki, Osamu Yokosuka, Emergence of entecavir-resistant mutations in nucleos(t)ide-naive Japanese patients infected with hepatitis B virus: Virological breakthrough is also dependent on adherence to medication, Scandinavian Journal of Gastroenterology, 2011, 46, 9, 1111

    CrossRef

  44. 44
    Gillian M. Keating, Entecavir, Drugs, 2011, 71, 18, 2511

    CrossRef

  45. 45
    Michael Chang, Sammy Saab, Interferon for Hepatitis B: Which Populations Benefit the Most, Current Hepatitis Reports, 2011, 10, 4, 285

    CrossRef

  46. 46
    Lucia Taramasso, Patrizia Caligiuri, Antonio Di Biagio, Bianca Bruzzone, Raffaella Rosso, Giancarlo Icardi, Claudio Viscoli, Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis B, Journal of Medical Virology, 2011, 83, 11
  47. 47
    J. Fung, C.-L. Lai, W.-K. Seto, M.-F. Yuen, Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B, Journal of Antimicrobial Chemotherapy, 2011, 66, 12, 2715

    CrossRef

  48. You have free access to this content48
    W. S. Ayoub, E. B. Keeffe, Review article: current antiviral therapy of chronic hepatitis B, Alimentary Pharmacology & Therapeutics, 2011, 34, 10